July 9, 2020 – Acist Medical Systems Inc., a Bracco Group Company, announced the global launch of its Acist Navvus II Rapid Exchange fractional flow reserve (FFR) microcatheter, the second-generation microcatheter for use with its Acist RXi Rapid Exchange FFR System.

July 8, 2020 – Judy W. Hung, M.D., FASE, took the helm as president of the American Society of Echocardiography (ASE) in late June. She has served on the ASE Board of Directors as vice president and president-elect prior to ascending to her one-year presidency. 

July 9, 2020 – The Minneapolis Heart Institute Foundation (MHIF) is conducting additional research on a novel hydrogel that is designed to repair cardiac tissue. In April 2020, the FDA approved an investigational new drug (IND) application to investigate the safety and feasibility of delivering VentriGel via catheter into areas of the heart of patients that cannot be completely revascularized at the time of coronary artery bypass grafting (CABG). 

July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agreement to deliver on the Trusts’ vision to set new standards of excellence for cardiac care in the U.K. and globally. The partnership will combine the latest innovations in technology for integrated cardiovascular solutions. The aim of the partnership is better health outcomes, lower cost of care and an improved experience for patients and staff.

July 7, 2020 – MedAlliance announced enrollment of the first patient in its study of Selution SLR 0.014 drug-eluting balloon (DEB) for the treatment of in-stent restenosis (ISR). This is the first DEB accepted by the FDA for its breakthrough program. The Selution SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting stent (DES).

The Medis QFR technology allows non-invasive functional FFR assessment of coronary flow based on standard X-ray angiographic images in the cath lab without the use of a pressure wire.

Fractional flow reserve (FFR) pressure wires have been used now in interventional cardiology procedures for more than a decade to determine the physiological significance of a coronary lesion and decide if a stent is required. But in the past couple years, several new FFR assessment technologies have gained U.S. Food and Drug Administration (FDA) approval, including simplified hyperemia-free technologies and image based FFR assessments.

July 7, 2020 – Medtronic announced it received U.S. Food and Drug Administration (FDA) clearance and European CE mark approval for its Linq II insertable cardiac monitor (ICM) with remote programming, which enables clinicians to optimize device settings without the need for patients to return to the office or hospital.

Canon Medical Systems USA has created a virtual trade-show experience for its cardiovascular computed tomography (CT) offerings at the 2020 Society of Cardiovascular Computed Tomography (SCCT) virtual meeting July 16-19. With CT positioned as a first-line diagnostic tool addressing the evolving needs of cardiac imaging, hospitals have the ability to deliver high quality, consistent CT studies that are critical to outcomes. 

July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major adverse outcomes, including death, compared to white patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now